Role of Radiation in Metastatic Prostate Cancer: Primary and Metastatic Sites
Dr. Curtland Deville, MD, presents how radiation supports the treatment of metastatic prostate cancer.
Read More
Curtiland Deville, Jr., MD, FASTRO, FACR
Johns Hopkins Medicine, Sibley Memorial Hospital
Washington, DC
Curtiland Deville, Jr., MD, FASTRO, FACR, is an Associate Professor of Radiation Oncology and Molecular Radiation Sciences at Johns Hopkins in Washington, DC. Dr. Deville also serves as the Medical Director of the Johns Hopkins Proton Therapy Center, Clinical Director of Radiation Oncology at Sibley Memorial Hospital, and Co-Director of the Kimmel Cancer Center Prostate Multidisciplinary Clinic at Sibley Memorial Hospital in Washington, DC. He is an expert in proton therapy and a leader in several institutional and national clinical trials. Dr. Deville’s clinical interests include genitourinary malignancies, including prostate cancer, and soft tissue sarcomas.
Dr. Deville earned his medical degree from Brown University in Providence, Rhode Island. He completed a residency in Radiation Oncology at the University of Pennsylvania in Philadelphia.
Dr. Deville’s research interests involve targeting tumors more effectively through proton and photon therapies, while minimizing radiation exposure to healthy tissues. He analyzes toxicity rates with modern radiation techniques and uses the most advanced technology for his patients’ care. Dr. Deville is also a Senior Editor for Advances in Radiation Oncology, as well as a reviewer for several journals that focus on radiation oncology. He has served as the Chair of the American Society of Radiation Oncology’s Committee on Health Equity, Diversity and Inclusion and the American Society of Clinical Oncology’s Diversity in Oncology Subcommittee.
Talks by Curtiland Deville, Jr., MD, FASTRO, FACR